Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Morphic Holding Inc (NQ: MORF ) 32.46 -1.06 (-3.16%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 757,008 Open 33.29 Bid (Size) 30.00 (1) Ask (Size) 35.83 (1) Prev. Close 33.52 Today's Range 31.33 - 33.29 52wk Range 19.34 - 62.08 Shares Outstanding 36,415,045 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Morphic to Participate in Jefferies Global Healthcare Conference May 31, 2024 From Morphic Therapeutic Via GlobeNewswire Morphic Demonstrates Novel Real-Time Visualization of Small Molecule α4β7 Inhibition of Gut-Trafficking Cells May 21, 2024 From Morphic Therapeutic Via GlobeNewswire Performance YTD +12.20% +12.20% 1 Month +5.48% +5.48% 3 Month -5.61% -5.61% 6 Month +5.84% +5.84% 1 Year -40.99% -40.99% More News Read More Morphic to Participate in RBC Capital Markets Global Healthcare Conference May 09, 2024 From Morphic Therapeutic Via GlobeNewswire Recap: Morphic Holding Q4 Earnings February 22, 2024 Via Benzinga MORF Stock Earnings: Morphic Holding Beats EPS for Q1 2024 April 25, 2024 Via InvestorPlace Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024 April 25, 2024 From Morphic Therapeutic Via GlobeNewswire Morphic Holding, Inc. (MORF) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings April 02, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire Morphic Holding, Inc. (MORF) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings March 26, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire MORF Investor Notice: Abraham, Fruchter & Twersky, LLP Investigating Claims on Behalf of Investors of Morphic Holding, Inc. (NASDAQ:MORF) March 20, 2024 From Abraham, Fruchter & Twersky, LLP Via GlobeNewswire Morphic Appoints Dr. Simon Cooper as Chief Medical Officer March 19, 2024 From Morphic Therapeutic Via GlobeNewswire Morphic to Participate in March Investor Conferences March 05, 2024 From Morphic Therapeutic Via GlobeNewswire Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023 February 22, 2024 From Morphic Therapeutic Via GlobeNewswire INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors January 11, 2024 From Law Offices of Howard G. Smith Via Business Wire Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors January 10, 2024 From Glancy Prongay & Murray LLP Via Business Wire The Law Offices of Frank R. Cruz Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors January 04, 2024 From The Law Offices of Frank R. Cruz Via Business Wire Morphic to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 03, 2024 From Morphic Therapeutic Via GlobeNewswire Robbins LLP Reminds MORF Investors that it is Investigating Morphic Holdings, Inc. on Behalf of Investors December 01, 2023 From Robbins LLP Via Business Wire Morphic Holding, Inc. Reminder: Robbins LLP is Investigating MORF on Behalf of Investors November 22, 2023 From Robbins LLP Via Business Wire Morphic to Present at November Investor Conferences November 10, 2023 From Morphic Therapeutic Via GlobeNewswire Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2023 November 03, 2023 From Morphic Therapeutic Via GlobeNewswire NASDAQ: MORF Investor Notice: Investigation over Possible Securities Laws Violations by Morphic Holding, Inc. November 01, 2023 Via SBWire Morphic Holding Investigation: Johnson Fistel Encourages Shareholders with Losses to Contact the Firm Regarding Investigation October 21, 2023 From Johnson Fistel, LLP Via Business Wire Morphic Holding SHAREHOLDER ALERT: Johnson Fistel Encourages Morphic Holding Shareholders with Losses to Contact the Firm Regarding Investigation October 14, 2023 From Johnson Fistel, LLP Via Business Wire Morphic Therapeutic to Host Webcast to Present EMERALD-1 Full Data Set October 09, 2023 From Morphic Therapeutic Via GlobeNewswire MORF INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into Morphic Holding, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm September 29, 2023 From Robbins Geller Rudman & Dowd LLP Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
